KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cme Group (CME) Other Non-Current Liabilities: 2009-2025

Historic Other Non-Current Liabilities for Cme Group (CME) over the last 17 years, with Sep 2025 value amounting to $725.7 million.

  • Cme Group's Other Non-Current Liabilities fell 5.68% to $725.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $725.7 million, marking a year-over-year decrease of 5.68%. This contributed to the annual value of $721.2 million for FY2024, which is 9.65% down from last year.
  • Cme Group's Other Non-Current Liabilities amounted to $725.7 million in Q3 2025, which was up 0.76% from $720.2 million recorded in Q2 2025.
  • In the past 5 years, Cme Group's Other Non-Current Liabilities ranged from a high of $1.1 billion in Q1 2021 and a low of $720.2 million during Q2 2025.
  • Its 3-year average for Other Non-Current Liabilities is $773.5 million, with a median of $783.2 million in 2024.
  • Data for Cme Group's Other Non-Current Liabilities shows a maximum YoY dropped of 17.55% (in 2022) over the last 5 years.
  • Over the past 5 years, Cme Group's Other Non-Current Liabilities (Quarterly) stood at $896.5 million in 2021, then decreased by 7.86% to $826.0 million in 2022, then decreased by 3.37% to $798.2 million in 2023, then fell by 9.65% to $721.2 million in 2024, then decreased by 5.68% to $725.7 million in 2025.
  • Its Other Non-Current Liabilities was $725.7 million in Q3 2025, compared to $720.2 million in Q2 2025 and $721.2 million in Q1 2025.